A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial
- DOI
- 10.1038/s41591-026-04686-y
- Published
- 2026-11-03
- Container
- Nature Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-026-04686-y,
title = {A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial},
author = {Doris M. Ponce and Zachariah DeFilipp and Christopher B. Ford and Bina Tejura and Mary-Jane Lombardo and David I. Lichter and Meghan Chafee and Satyajit Kosuri and Nandita Khera and Hemant S. Murthy and Karamjeet S. Sandhu and David N. Fredricks and Tessa Andermann and Rajneesh Nath and Kelly Brady and Brooke R. Hasson and Emily Walsh and Nathan Hicks and Jonathan U. Peled and Lisa von Moltke and Matthew R. Henn and Marcel R. M. van den Brink and Dennis M. Walling and Unknown and William J. Hogan and Nosha Farhadfar and Steven Tsai and Zeina Al-Mansour and Chirag Patel and Swarna Pandian and Kankana Bardhan and Sean Sykes},
year = {2026},
journal = {Nature Medicine},
doi = {10.1038/s41591-026-04686-y},
url = {https://doi.org/10.1038/s41591-026-04686-y}
}RIS
TY - JOUR TI - A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial AU - Doris M. Ponce AU - Zachariah DeFilipp AU - Christopher B. Ford AU - Bina Tejura AU - Mary-Jane Lombardo AU - David I. Lichter AU - Meghan Chafee AU - Satyajit Kosuri AU - Nandita Khera AU - Hemant S. Murthy AU - Karamjeet S. Sandhu AU - David N. Fredricks AU - Tessa Andermann AU - Rajneesh Nath AU - Kelly Brady AU - Brooke R. Hasson AU - Emily Walsh AU - Nathan Hicks AU - Jonathan U. Peled AU - Lisa von Moltke AU - Matthew R. Henn AU - Marcel R. M. van den Brink AU - Dennis M. Walling AU - Unknown AU - William J. Hogan AU - Nosha Farhadfar AU - Steven Tsai AU - Zeina Al-Mansour AU - Chirag Patel AU - Swarna Pandian AU - Kankana Bardhan AU - Sean Sykes PY - 2026 JO - Nature Medicine DO - 10.1038/s41591-026-04686-y UR - https://doi.org/10.1038/s41591-026-04686-y ER -
APA
Ponce, D. M., DeFilipp, Z., Ford, C. B., Tejura, B., Lombardo, M., Lichter, D. I., Chafee, M., Kosuri, S., Khera, N., Murthy, H. S., Sandhu, K. S., Fredricks, D. N., Andermann, T., Nath, R., Brady, K., Hasson, B. R., Walsh, E., Hicks, N., Peled, J. U., Moltke, L. V., Henn, M. R., Brink, M. R. M. V. D., Walling, D. M., Unknown, Hogan, W. J., Farhadfar, N., Tsai, S., Al-Mansour, Z., Patel, C., Pandian, S., Bardhan, K., & Sykes, S. (2026). A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial. Nature Medicine. https://doi.org/10.1038/s41591-026-04686-y
Source records
- crossref · retrieved 2026-11-07T02:02:47.713Z